MYOM2 and Miyoshi myopathy: MM is part of a group of pathologies defined as monoclonal gammopathies (whose classification is based both on the amount of M protein in the urine and on the plasma cell percentage), which also include the monoclonal gammopathy of uncertain significance (MGUS), smoldering MM and overt MM [4,6,7,8,9,10].